Therapeutic potential of a novel virulent bacteriophage XQ-1 against avian pathogenic Escherichia coli infection in broiler chickens.
Avian Pathogenic Escherichia coli (APEC) represents a significant subgroup within extraintestinal pathogenic Escherichia coli strains and constitutes a substantial threat to the global poultry industry. Although the negative impacts of APEC have been mitigated considerably through antibiotic use, this practice has concurrently facilitated the widespread emergence and dissemination of antibiotic-resistant APEC strains worldwide. Consequently, bacteriophage has emerged as a promising alternative to antibiotics. In the current study, a novel virulent bacteriophage, designated XQ-1, was isolated from a sewage sample collected at a broiler chickens farm in Hubei Province, China. Notably, this bacteriophage exhibited the capability to lyse multiple APEC strains, including O1, O2, and O78 serotypes. The optimal multiplicity of infection (MOI) for bacteriophage XQ-1 was determined to be 0.001, yielding a maximum viral titer of 4.73 ± 0.31 × 1011 plaque-forming units (PFU) per milliliter. This bacteriophage displayed a latent period of 30 min, and a burst period of 80 minutes, corresponding to a burst size of 348 PFU per infected cell. Additionally, bacteriophage XQ-1 retained high lytic activity across a temperature range of 4-50 °C and maintained tolerance with a pH range of 3-11. Further in vitro studies demonstrated that bacteriophage XQ-1 holds potential as an effective disinfectant capable of directly lysing APEC strain JZ-1. In chick models subjected to intraperitoneal injection, exposure to APEC resulted in 100% mortality in chicks. However, treatment with bacteriophage XQ-1 significantly improved the survival rates of infected broiler chickens, reduced organ indexes, decreased bacterial loads in the liver and heart organs, and mitigated intestinal damage caused by APEC infection. Collectively, these findings suggest that bacteriophage XQ-1 represents a promising candidate for the prevention and treatment of APEC infections in poultry.